Interferon Gamma-1b

TERMINATED · PHASE1, PHASE2 · Non-Hodgkin's Lymphoma

administrative reasons

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.